Taiwan FDA registration f6968966f6464ced0e0c00b4f0bedff8
Thys automatic red blood cell sedimentation rate device
TW: 蒂艾思自動紅血球沉降速率裝置
Taiwan·Risk Class 2·DIESSE DIAGNOSTICA SENESE S.P.A.·Registered Jun 22, 2006 – Jun 22, 2021CancelledRegistration details
- Analysis ID
- f6968966f6464ced0e0c00b4f0bedff8
- Customs Code
- DHA00601685004
Company information
- Manufacturer
- DIESSE DIAGNOSTICA SENESE S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- GRANT TECHNOLOGY CO., LTD.
Product details
- Intended Use
- Determination of erythrocyte sedimentation rate in human blood samples.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5800 Automatic settling rate device
- Import Information
- import
Dates and status
- Registration Date
- Jun 22, 2006
- Expiry Date
- Jun 22, 2021
- Cancellation Date
- Aug 28, 2023
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Thys automatic red blood cell sedimentation rate device in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number f6968966f6464ced0e0c00b4f0bedff8 and manufactured by DIESSE DIAGNOSTICA SENESE S.P.A.. The authorized representative in Taiwan is GRANT TECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices